Back
Download your free ''HTA Process in the UK'' Guide

    Articles and Publications

    Explore our research and published work

    Cardiovascular Diseases

    Digital variance angiography in patients undergoing lower limb arterial recanalization: cost–effectiveness analysis within the English healthcare setting – Journal of Comparative Effectiveness Research 13 (4), e230068 – 2024 – A Ansaripour, E Moloney, M Branagan-Harris, L Patrone, M Javanbakht …

    Cost-Effectiveness Analysis of Intravascular Targeted Temperature Management after Cardiac Arrest in England – PharmacoEconomics-Open 6 (4), 549-562 – 2022 – M Javanbakht, A Mashayekhi, MR Hemami, M Branagan-Harris, …

    Cost-effectiveness of an enhanced Paramedic Acute Stroke Treatment Assessment (PASTA) during emergency stroke care: Economic results from a pragmatic cluster randomized trial – International Journal of Stroke 17 (3), 282-290 – 2022 – N Bhattarai, CI Price, P McMeekin, M Javanbakht, L Vale, GA Ford, …

    Economic Analysis of the CADScor System for Ruling Out Coronary Artery Disease in England – PharmacoEconomics-Open 6 (1), 123-135 – 2022 – M Javanbakht, A Mashayekhi, MR Hemami‬, M Branagan-Harris, …

    Cost-effectiveness analysis of Intravascular Temperature Management after cardiac arrest in England – medRxiv, 2021.08. 16.21262120 – 2021 – M Yaghoubi, M Javanbakht, A Mashayekhi, MR Hemami, …

    Effect of an Enhanced Paramedic Acute Stroke Treatment Assessment on Thrombolysis Delivery During Emergency Stroke CareA Cluster Randomized Clinical Trial – JAMA neurology 77 (7), 840-848 – 2020 – CI Price, L Shaw, S Islam, M Javanbakht, A Watkins, P McMeekin, …

    Ticagrelor Removal by CytoSorb® in Patients Requiring Emergent or Urgent Cardiac Surgery: A UK-Based Cost-Utility Analysis – PharmacoEconomics-Open 4, 307-319 – 2020 – M Javanbakht, M Trevor, M Rezaei Hemami, K Rahimi, …

    The challenge of mimic conditions during pre-hospital stroke research: screening data from the Paramedic Acute Stroke Treatment Assessment (PASTA) trial. – International Journal of Stroke 14 (4 Supplement), 50 – 2019 – C Price, L Shaw, S Islam, M Javanbakht, A Watkins, P McMeekin, …

    COST UTILITY ANALYSIS OF TICAGRELOR REMOVAL BY CYTOSORB® IN PATIENTS REQUIRING EMERGENT OR URGENT CARDIAC SURGERY IN THE UK – ISPOR Europe 2019 – 2019 – M Javanbakht, M Trevor, K Rahimi, M Branagan-Harris, F Degener, …

    CytoSorb for ticagrelor removal in cardiac surgery cost saving – PharmacoEconomics & Outcomes News 840, 10-2 – 2019 – M Javanbakht

    PCV112 Cost utility analysis of Ticagrelor removal by Cytosorb® in patients requiring emergent or urgent cardiac surgery in the UK – Value in Health 22, S562 – 2019 – M Javanbakht, M Trevor, K Rahimi, M Branagan-Harris, F Degener, …

    Systematic Review of Economic Models Used to Compare Techniques for Detecting Peripheral Arterial Disease – PharmacoEconomics-open 3, 21-30 – 2019 – E Moloney, J O’Connor, D Craig, S Robalino, A Chrysos, M Javanbakht, …

    Comparison of health-related quality of life after percutaneous coronary intervention and coronary artery bypass surgery – ARYA atherosclerosis 12 (3), 124 – 2016 – R Yazdani-Bakhsh, M Javanbakht, M Sadeghi, A Mashayekhi, H Ghaderi, …

    A Cluster Randomized Noninferiority Field Trial of Gestational Diabetes Mellitus Screening – The Journal of Clinical Endocrinology & Metabolism 107 (7), e2906-e2920 – 2022 – F Ramezani Tehrani, S Behboudi-Gandevani, F Farzadfar, …

    Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland – Diabetic Medicine 33 (7), 886-895 – 2016 – G Scotland, P McKeigue, S Philip, GP Leese, JA Olson, HC Looker, …

    Economics cost of diabetes in type II diabetic patients. – Payesh 11 (4), 443-449 – 2012 – MA SADEGHI, E Kharazmi, M Javanbakht, A Heidari, M Bayati

    Cost-Utility Analysis of the Caresyntax Platform to Identify Patients at Risk of Surgical Site Infection Undergoing Colorectal Surgery – PharmacoEconomics-Open 7 (2), 285-298 – 2023 – E Moloney, A Mashayekhi, M Javanbakht, MR Hemami, …

    Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis – European Journal of Surgical Oncology 48 (1), 188-196 – 2022 – M Javanbakht, A Mashayekhi, M Branagan-Harris, P Horvath, …

    Cost-utility analysis of normothermic liver perfusion with the OrganOx metra compared to static cold storage in the United Kingdom – Journal of medical economics 23 (11), 1284-1292 – 2020 – M Javanbakht, A Mashayekhi, M Trevor, M Branagan-Harris, J Atkinson

    Cost–utility analysis of oral deferasirox versus infusional deferoxamine in transfusion-dependent β-thalassemia patients – Transfusion 53 (8), 1722-1729 – 2013 – A Keshtkaran, M Javanbakht, S Salavati, A Mashayekhi, M Karimi, B Nuri